Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

凯泽百 - NMPA Drug Approval Details

Approvals/NMPA/Dinutuximab beta Injection

Approved

生物制品

Dinutuximab beta Injection

Recordati Netherlands B.V.🇨🇳 National Medical Products Administration

Approval Date: Aug 12, 2021
Approval ID: 8BYsVKAH9cJ
Company: Recordati Netherlands B.V.
Type: 生物制品

Approval Details

Approval Id: 8BYsVKAH9cJ
Approval Number: 国药准字SJ20210023
Generic Name: 达妥昔单抗β注射液
Generic Name En: Dinutuximab beta Injection
Trade Name: 凯泽百
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 20mg（4.5ml）/瓶
Reg Date: 2021-08-12
Expired Date: 2026-08-11
Company Name: Recordati Netherlands B.V.
Production Company Name: PATHEON ITALIA SPA
Company Detail Path: /organization/recordati-netherlands-b-v
Production Company Detail Path: /organization/patheon-italia-spa

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 12, 2021

Approval ID

8BYsVKAH9cJ

Type

生物制品

Back to NMPA Approvals